A blog about chemistry, drug development, science, and technology
I mentioned in a previous post about the biogeneric boom that some companies weren’t waiting to see what the FDA may decide and were buying companies outside the US. One of those I mentioned was Barr and it seems they announced their offer today for Pliva.
Barr Initiates Formal Tender Offer for PLIVA d.d.
Here is an unofficial translation of the offer (pdf) from Pliva’s website. I’m not familiar with Pliva but they have been around since 1921 and in the 1930’s made sulphonamide and macrolide antibiotics. They claim the discovery of azithromycin sold by Pfizer as Zithromax and it is sold in central and eastern Europe under the tradename Sumamed.
I am hopeful that biogenerics will come to market but I am fearful that it will happen much sooner in Europe than in the US.
For more information, here is the news articles from Yahoo and Google containing both Barr and Pliva.
• Yahoo! News Search Results for pliva barr
• pliva barr - Google News
And here are results for Barr and Pliva using Google Blog Seach and Yahoo Blog Search.
• Google Blog Search: barr pliva
• Yahoo! Search Results for barr pliva
Technorati Tags: Barr Labs, Pliva
Bookmark it with:
|
del.icio.us
|
Digg it
|
Furl
|
Simpy
|
Spurl
|
My Yahoo!
|
[powered by WordPress.]
QDIS: blogging about chemistry, drug development, science and technology.

By Category
Chemistry, science, and technology for the future.

35 queries. 1.387 seconds